Stock Track | OrthoPediatrics (KIDS) Soars 5.29% as Analysts Raise Targets and Company Reports Strong Growth

Stock Track

Mar 05, 2025

OrthoPediatrics Corp (NASDAQ: KIDS) saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.

On the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.

The company itself provided ample reasons for investors to be optimistic about its prospects. In its recent earnings report, OrthoPediatrics announced a record 40% increase in total revenue for the fourth quarter of 2024, reaching $52.7 million. This impressive growth was fueled by strong performances across its trauma, deformity, and scoliosis segments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1101988030"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101988030\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101988030?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101988030","market":"us","top_or_hot":-1,"title":"Stock Track | OrthoPediatrics (KIDS) Soars 5.29% as Analysts Raise Targets and Company Reports Strong Growth","media":"Stock Track","content":"<p>OrthoPediatrics Corp (NASDAQ: KIDS) saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.</p>\n\n<p>On the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.</p>\n\n<p>The company itself provided ample reasons for investors to be optimistic about its prospects. In its recent earnings report, OrthoPediatrics announced a record 40% increase in total revenue for the fourth quarter of 2024, reaching $52.7 million. This impressive growth was fueled by strong performances across its trauma, deformity, and scoliosis segments.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | OrthoPediatrics (KIDS) Soars 5.29% as Analysts Raise Targets and Company Reports Strong Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | OrthoPediatrics (KIDS) Soars 5.29% as Analysts Raise Targets and Company Reports Strong Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-05 23:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OrthoPediatrics Corp (NASDAQ: KIDS) saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.</p>\n\n<p>On the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.</p>\n\n<p>The company itself provided ample reasons for investors to be optimistic about its prospects. In its recent earnings report, OrthoPediatrics announced a record 40% increase in total revenue for the fourth quarter of 2024, reaching $52.7 million. This impressive growth was fueled by strong performances across its trauma, deformity, and scoliosis segments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KIDS","symbol_name":"Orthopediatrics Corp","start_time":0,"source_url":"","article_id":"1101988030","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101988030","pubTimestamp":1741186945,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"OrthoPediatrics Corp  saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.On the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.The company itself provided ample reasons for investors to be o","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KIDS":"Orthopediatrics Corp"},"translate_title":"随着分析师提高目标且公司报告强劲增长，OrthoPediatrics(KIDS)股价飙升5.29%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KIDS":1},"content_text":"OrthoPediatrics Corp (NASDAQ: KIDS) saw its stock soar by 5.29% in the intraday trading session on Wednesday, driven by positive analyst actions and strong financial performance reported by the company.\nOn the analyst front, Truist Securities adjusted its price target for KIDS to $26 from $25, maintaining a Hold rating. Meanwhile, Needham maintained its bullish stance, keeping its price target at $42 per share for the pediatric orthopedics company.\nThe company itself provided ample reasons for investors to be optimistic about its prospects. In its recent earnings report, OrthoPediatrics announced a record 40% increase in total revenue for the fourth quarter of 2024, reaching $52.7 million. This impressive growth was fueled by strong performances across its trauma, deformity, and scoliosis segments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}